Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Risk-based testing alone has failed to identify a majority of people living with chronic HBV.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
Everything you consume and are exposed to is processed by your liver. It’s important to know what’s a friend or foe to your liver.
A person can be infected for years without having symptoms of hepatitis C. During that time, their liver is being damaged.
This new test could “play an important role” in screening people who are at risk for developing hepatocellular carcinoma.
Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.
Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.
Liver cancer development is strongly associated with hep B.
The National Institute for Health and Care has recommended a less invasive option for testing fibrosis among people with liver inflammation.
I’ve been thinking about blood tests. I’m on holidays, I have to do something! Do we over-test? I’ve been pondering this question.
The moment of truth has arrived. After three months on treatment the results of my first post-treatment blood test are in.
How long will it take before a positive hep C test is not the first someone knows about the risk of sexually transmitted hepatitis C?
The next few weeks, leading up to my first post-treatment blood test, are going to be the hardest yet in my hep C journey
Many people who have lived with hep C for a long time are keen to get access to interferon-free treatment via a clinical trail.
Although blood test results have come back negative, the man says he is still planning to file criminal charges.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.